(Q40476911)

20 September 2017

1 reference

title

Current Knowledge of Medications for the Treatment of Childhood Anxiety Disorders (English)

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

31 July 2024

author name string

A. J. Allen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665455

31 July 2024

H. Leonard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665455

31 July 2024

S. E. Swedo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665455

31 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7665455

31 July 2024

publication date

1 August 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:S0890856709633414?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

https://api.elsevier.com/content/article/PII:S0890856709633414?httpAccept=text/plain

31 July 2024

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Journal of the American Academy of Child and Adolescent Psychiatry

31 July 2024

published in

1 reference

20 September 2017

volume

34

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

976-986

1 reference

Practice parameters for the assessment and treatment of anxiety disorders. American Academy of Child and Adolescent Psychiatry

20 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression

31 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Three cases of panic disorder with agoraphobia in children

31 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

School phobia: a therapeutic trial with clomipramine and short-term outcome

31 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Comparative studies of pharmacotherapy for school refusal

31 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Fluoxetine for childhood anxiety disorders

31 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Panic disorder in children and adolescents

31 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Elective mutism as a variant of social phobia

31 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study

31 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Pharmacotherapy in early infantile autism

31 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Imipramine in preschool autistic and schizophrenic children

31 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

The masquerade of mutism.

31 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Chlordiazepoxide in management of school phobia

31 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

31 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

The effect of acute beta-adrenoceptor blockade on examination performance

31 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

31 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Drug therapy in child psychiatry: pharmacological aspects.

31 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

31 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Effects of imipramine on depression and obsessive-compulsive symptoms

31 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Treatment of childhood depression with antidepressant drugs

31 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Panic disorder on a child psychiatric consultation service

31 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

31 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

31 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Phenelzine treatment of elective mutism: a case report

31 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

31 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

31 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Differential response of seven subjects with autistic disorder to clomipramine and desipramine

31 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder

31 July 2024

46

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Clonazepam in childhood anxiety disorders

31 July 2024

47

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo

31 July 2024

50

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory

31 July 2024

51

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Imipramine treatment of children with separation anxiety disorder

31 July 2024

54

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Classification and diagnosis of depression in school phobia

31 July 2024

56

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

EEG and behavioral effects of drug therapy in children. Chlorpromazine and diphenhydramine

31 July 2024

57

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

CHLORDIAZEPOXIDE IN TREATMENT OF CHILDREN WITH EMOTIONAL DISTURBANCES

31 July 2024

59

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Use of buspirone in an adolescent with overanxious disorder

31 July 2024

60

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Oxprenolol in the treatment of examination stress

31 July 2024

61

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

31 July 2024

68

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

31 July 2024

69

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

31 July 2024

70

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

31 July 2024

72

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Psychoactive drugs in the treatment of emotionally disturbed children: Haloperidol and diazepam

31 July 2024

73

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Beta-blocking drugs and anxiety

31 July 2024

74

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

31 July 2024

76

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Tricyclic nonresponders: phenomenology and treatment

31 July 2024

78

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Imipramine in adolescent major depression: plasma level and clinical response

31 July 2024

79

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Current status of research activity in American child and adolescent psychiatry: Part I.

31 July 2024

80

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

31 July 2024

82

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type).

31 July 2024

85

1 reference

https://api.crossref.org/works/10.1097/00004583-199508000-00007

31 July 2024

Identifiers

1 reference

20 September 2017

1 reference